For decades, men have been told that testosterone “feeds” prostate cancer.But is that actually what the modern data shows?In this video, I break down the real relationship between testosterone, TRT, PSA, and prostate cancer risk — including where the fear came from, why the old “fuel for the fire” model may be too simplistic, and what newer studies suggest about properly monitored testosterone therapy.We’ll cover:• Why prostate cancer is androgen-sensitive• The 1941 Huggins and Hodges study that shaped decades of thinking• Why advanced prostate cancer is not the same as low testosterone in otherwise evaluated men• The saturation model• What modern TRT safety data suggests• Why PSA monitoring still matters• When testosterone therapy requires cautionTestosterone is not a decision to make casually. But fear alone is not a medical strategy.The key is context, baseline evaluation, and careful monitoring.👉 Free Biopsy Checklist — 5 Questions to Ask Before Prostate Biopsy:https://drchovanec.kit.com/30968ddb5c📘 Optional Paid PSA Guide:A concise printable guide to help you understand PSA, MRI, biopsy decisions, and the diagnostic pathway.All core education is covered for free in my videos — this guide simply organizes it in one place.https://chovano.gumroad.com/l/luikhiSubscribe for calm, evidence-based prostate cancer education.—Dr. Michal ChovanecMedical OncologistHelping men make informed decisions about prostate cancer screening, diagnosis, and treatment.Medical disclaimer:This video is for educational purposes only and is not personal medical advice. Please discuss your individual situation with your doctor, especially before starting or stopping testosterone therapy.